ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,294.90
-0.34%
S&P ASX All Technology
4,035.20
-1.55%
Brent Oil
76.135
-0.22%
US Dollar vs AUD
1.56172
0.01%
Bitcoin
98,239.80
-0.08%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Nanobiotix SA (NBTX) Share Price

Nanobiotix SA

Nanobiotix SA (NBTX)

NASDAQ
3.95
0.35
(9.72%)
Closed 21 February 8:00AM
Delayed by 15 minutes
3.95
0.00
(0.00%)
After Hours: 10:00AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
3.95
Bid
3.30
Offer
5.40
Volume
15,676
3.70 Day's Range 3.95
0.00 52 Week Range 0.00
Market Cap
186.177M
Previous Close
3.60
Open
3.72
Last Trade
12
@
3.81
Last Trade Time
Financial Volume
US$ 59,188
VWAP
3.7757
Average Volume (3m)
-
Shares Outstanding
47,133,328
Dividend Yield
-
PE Ratio
-4.30
Earnings Per Share (EPS)
-0.84
Revenue
36.21M
Net Profit
-39.7M

About Nanobiotix SA

Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying ... Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its lead product candidate is NBTXR3, a preclinical research program for cancer immunotherapies. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.nanobiotix.com
Headquarters
Paris, Paris, Fra
Founded
-
Nanobiotix SA is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NBTX. The last closing price for Nanobiotix was US$3.60. Over the last year, Nanobiotix shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Nanobiotix currently has 47,133,328 shares in issue. The market capitalisation of Nanobiotix is US$169.68 million. Nanobiotix has a price to earnings ratio (PE ratio) of -4.30.

Ask ADVFN Intelligence (AI)

NBTX Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
13 February 2025
NBTX (9.72%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
30 January 2025
NBTX (9.72%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
21 January 2025
NBTX (9.72%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
10 January 2025
NBTX (9.72%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
18 December 2024
NBTX (9.72%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
17 December 2024
NBTX (9.72%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
13 December 2024
NBTX (9.72%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
12 December 2024
NBTX (9.72%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

NBTX - Frequently Asked Questions (FAQ)

What is the current Nanobiotix share price?
The current share price of Nanobiotix is US$ 3.95
How many Nanobiotix shares are in issue?
Nanobiotix has 47,133,328 shares in issue
What is the market cap of Nanobiotix?
The market capitalisation of Nanobiotix is USD 169.68M
What is the 1 year trading range for Nanobiotix share price?
Nanobiotix has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Nanobiotix?
The price to earnings ratio of Nanobiotix is -4.3
What is the cash to sales ratio of Nanobiotix?
The cash to sales ratio of Nanobiotix is 4.71
What is the reporting currency for Nanobiotix?
Nanobiotix reports financial results in EUR
What is the latest annual turnover for Nanobiotix?
The latest annual turnover of Nanobiotix is EUR 36.21M
What is the latest annual profit for Nanobiotix?
The latest annual profit of Nanobiotix is EUR -39.7M
What is the registered address of Nanobiotix?
The registered address for Nanobiotix is 60 RUE DE WATTIGNIES, PARIS, PARIS, 75012
What is the Nanobiotix website address?
The website address for Nanobiotix is www.nanobiotix.com
Which industry sector does Nanobiotix operate in?
Nanobiotix operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MNDRMobile health Network Solutions
US$ 0.934099
(183.66%)
451.07M
XOSXos Inc
US$ 6.245
(99.52%)
93.25M
STSSSharps Technology Inc
US$ 0.5185
(44.55%)
76.11M
YSXTYSX Tech Company Ltd
US$ 3.4999
(42.85%)
447.78k
AGHAureus Greenway Holdings Inc
US$ 5.47
(41.71%)
2.49M
WOKWORK Medical Technology Group Ltd
US$ 1.30
(-47.79%)
112.25M
EDITEditas Medicine Inc
US$ 2.0556
(-35.76%)
14.93M
MTLSMaterialise NV
US$ 5.98
(-35.14%)
2.63M
MULNMullen Automotive Inc
US$ 5.125
(-28.32%)
1.3M
JTAIJet AI Inc
US$ 7.32
(-27.88%)
7.39M
MNDRMobile health Network Solutions
US$ 0.934099
(183.66%)
451.07M
PLTRPalantir Technologies Inc
US$ 106.27
(-5.17%)
228.01M
ADTXAditxt Inc
US$ 0.1156
(-10.11%)
202.11M
SMCISuper Micro Computer Inc
US$ 59.27
(-1.63%)
174.43M
APTOAptose Biosciences Inc
US$ 0.188
(25.42%)
164.63M

NBTX Discussion

View Posts
glenn1919 glenn1919 2 months ago
NBTX.......................https://stockcharts.com/h-sc/ui?s=NBTX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 months ago
NBTX...........................https://stockcharts.com/h-sc/ui?s=NBTX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 months ago
NBTX 10Q due 4/3
👍️0
Monksdream Monksdream 11 months ago
NBTX under $10
👍️0
Monksdream Monksdream 2 years ago
Nanobiotix SA NASDAQ: NBTX

GoSymbol lookup
Health Care : Biotechnology | Small Cap Value | Based in FranceCompany profile
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
This security is an American depositary receipt
ADR Fees
👍️0
Monksdream Monksdream 2 years ago
July 10, 2023
4:21 am ET
*Nanobiotix shares are trading higher after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and commercialization of NBTXR3.
Benzinga
2:19 am ET
*Nanobiotix Enters License Agreement With Janssen Pharmaceutical For Worldwide Co-Development And Commercialization Of Potential First-In-Class Radioenhancer NBTXR3
Benzinga
Nanobiotix SA NASDAQ: NBTX

GoSymbol lookup
Health Care : Biotechnology | Small Cap Value | Based in FranceCompany profile
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
This security is an American depositary receipt
ADR Fees
👍️0

Your Recent History

NASDAQ
NBTX
Nanobiotix
BIT
UV8B1M
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads